BACKGROUND: Clinical studies have shown equivalent survival rates between breast-conserving surgery (BCS) and mastectomy in early breast cancer; however, rates for BCS remain low. The purpose of this study was to determine (a) the prevalence of BCS in a regional medical center, (b) clinicopathologic factors associated with BCS, and (c) patient perceptions of the treatment decision-making process. METHODS: We retrospectively reviewed 251 consecutive breast cancer cases during January 1990-December 1991; 77 patients were ineligible for BCS because of unfavorable pathology. We then interviewed 118 of the 160 women available for interview. RESULTS: BCS was performed in 31 of the eligible patients (18%). Multivariate analysis revealed that tumor size < 10 mm (p = 0.03) was the only significant predictive variable for BCS. Patient interviews revealed that 93% said their surgeon was the primary source of information regarding treatment options. Among 69% of the women whose surgeons reportedly recommended a particular option, 89% recommended mastectomy with 93% compliance, and 11% recommended BCS with 89% compliance. The BCS group more often obtained a second opinion (p = 0.04) and 60% said they made the decision themselves compared with only 37% of the mastectomy group (p = 0.05). CONCLUSION: Limiting BCS to women whose tumor size is < 10 mm is too restrictive; this excludes a large number of women who are clinically eligible for BCS. The surgical decision-making process for early-stage breast cancer is very much surgeon-driven, with a high degree of patient compliance.
BACKGROUND: Clinical studies have shown equivalent survival rates between breast-conserving surgery (BCS) and mastectomy in early breast cancer; however, rates for BCS remain low. The purpose of this study was to determine (a) the prevalence of BCS in a regional medical center, (b) clinicopathologic factors associated with BCS, and (c) patient perceptions of the treatment decision-making process. METHODS: We retrospectively reviewed 251 consecutive breast cancer cases during January 1990-December 1991; 77 patients were ineligible for BCS because of unfavorable pathology. We then interviewed 118 of the 160 women available for interview. RESULTS: BCS was performed in 31 of the eligible patients (18%). Multivariate analysis revealed that tumor size < 10 mm (p = 0.03) was the only significant predictive variable for BCS. Patient interviews revealed that 93% said their surgeon was the primary source of information regarding treatment options. Among 69% of the women whose surgeons reportedly recommended a particular option, 89% recommended mastectomy with 93% compliance, and 11% recommended BCS with 89% compliance. The BCS group more often obtained a second opinion (p = 0.04) and 60% said they made the decision themselves compared with only 37% of the mastectomy group (p = 0.05). CONCLUSION: Limiting BCS to women whose tumor size is < 10 mm is too restrictive; this excludes a large number of women who are clinically eligible for BCS. The surgical decision-making process for early-stage breast cancer is very much surgeon-driven, with a high degree of patient compliance.
Authors: U Veronesi; A Banfi; M Del Vecchio; R Saccozzi; C Clemente; M Greco; A Luini; E Marubini; G Muscolino; F Rilke Journal: Eur J Cancer Clin Oncol Date: 1986-09
Authors: B Fisher; C Redmond; R Poisson; R Margolese; N Wolmark; L Wickerham; E Fisher; M Deutsch; R Caplan; Y Pilch Journal: N Engl J Med Date: 1989-03-30 Impact factor: 91.245
Authors: A Liberati; G Apolone; A Nicolucci; C Confalonieri; R Fossati; R Grilli; V Torri; P Mosconi; A Alexanian Journal: Am J Public Health Date: 1991-01 Impact factor: 9.308
Authors: D Sarrazin; M G Lê; R Arriagada; G Contesso; F Fontaine; M Spielmann; F Rochard; T Le Chevalier; J Lacour Journal: Radiother Oncol Date: 1989-03 Impact factor: 6.280
Authors: Amy K Alderman; Sarah T Hawley; Monica Morrow; Barbara Salem; Ann Hamilton; John J Graff; Steven Katz Journal: Ann Surg Oncol Date: 2011-01-05 Impact factor: 5.344
Authors: Lisa J M Caldon; Karen A Collins; Malcolm W Reed; Stephanie Sivell; Joan Austoker; Alison M Clements; Julietta Patnick; Glyn Elwyn Journal: Health Expect Date: 2010-10-28 Impact factor: 3.377
Authors: Pragati Advani; Melissa Bondy; Patricia A Thompson; María Elena Martínez; Jesse N Nodora; Sally W Vernon; Pamela Diamond; Jason Burnett; Abenaa M Brewster Journal: J Cancer Surviv Date: 2018-07-25 Impact factor: 4.442